Dagyagnao, Carmen A.
HRN: 24-24-01 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/11/2023
CEFTRIAXONE 1G (VIAL)
12/11/2023
12/17/2023
IV
2g
OD
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes